PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign

PA-20-070 通过 eMAR 重新设计改善新冠肺炎期间的用药安全和护理工作流程

• 批准号: 10175229
• 负责人: Raj M Ratwani
• 金额: $ 24.53万
• 依托单位: MEDSTAR HEALTH RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-01 至 2023-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10175229
• 关键词: PA; 20; 070; Improving; Medication

PROJECT SUMMARY/ABSTRACT The proposed research is in direct response to AHRQ PA-20-070. We aim to support nursing workflow and reduce patient safety hazards associated with electronic medication administration records (eMARs) during pandemics such as COVID-19 by: (1) understanding pre-COVID-19 and COVID-19 medication administration workflows through analysis of health information technology and virtual interviews with nurses; and (2) developing and disseminating a medication administration workflow risk assessment tool to healthcare facilities and health information technology test cases to assess eMAR usability and safety. We will develop a broad understanding of medication administration workflow changes and health information technology needs pre COVDI-19 and during COVID-19 by comparing electronic data generated in interactions with medication administration technology these respective time periods. We will then conduct interviews with nurses to validate the medication administration workflows, and generate process maps to compare pre-COVID-19 vs. COVID-19 medication administration workflows with the goal of identifying safety risks. These data will inform the development of the risk assessment tool and usability test cases to be disseminated to healthcare facilities and technology vendors. This project utilizes the extensive expertise of the research team in human factors, health information technology, informatics and data science, and safety science. Our research team includes physicians, nurses, and human factors engineers. The proposal addresses fundamental aspects of the call for proposals by providing new insights on medication administration safety and health information technology to address challenges of pandemics such as COVID-19. Contributions from this research will include a fundamental understanding of the role of health information technology during medication administration with a focus on information flow, design, and development of a risk assessment tool and test cases for healthcare systems and technology vendors to meet the increased risks to patient safety during COVID-19.

项目摘要/摘要 拟议的研究直接响应AHRQ PA-20-070。我们旨在支持护理工作流程和 减少与电子药物管理记录（EMARS）相关的患者安全危害（EMARS） 诸如COVID-19的大流行者：（1）理解前COVID-19和COVID-19 通过分析健康信息技术和对护士的虚拟访谈来工作流程； （2） 开发和传播药物管理工作流风险评估工具到医疗机构 以及健康信息技术测试案例，以评估EMAR可用性和安全性。我们将发展广泛 了解药物管理工作流程变化和健康信息技术的需求 COVDI-19和COVID-19期间通过比较与药物相互作用中产生的电子数据 管理技术各自的时间段。然后，我们将对护士进行采访 验证药物管理工作流程，并生成工艺图以比较前旋转-19 vs。 COVID-19-COVID ADVINOPATION工作流程的目的是确定安全风险。这些数据将告知 风险评估工具和可用性测试案例的开发将被传播到医疗机构 和技术供应商。 该项目利用研究团队在人为因素，健康信息方面的广泛专业知识 技术，信息学和数据科学以及安全科学。我们的研究团队包括医生，护士， 和人为因素工程师。该提案涉及呼吁提案的基本方面 提供有关药物管理安全和健康信息技术的新见解，以解决 诸如Covid-19之类的大流传学的挑战。这项研究的贡献将包括一个基本 了解卫生信息技术在药物管理过程中的作用，重点 信息流，设计和开发风险评估工具和医疗保健系统的测试案例以及 技术供应商满足COVID-19期间患者安全风险的增加。